German health officials have accused Donald Trump of offering funds to CureVac, a German company to develop a coronavirus vaccine exclusively for the United States.

The news article by Reuters supports that German health officials accused Trump of offering funds to a German company for a vaccine for the U.S only.

The news article by Reuters supports that German health officials accused Trump of offering funds to a German company for a vaccine for the U.S only.Reuters reported that Berlin was trying to stop Washington from persuading a German company seeking a coronavirus vaccine to move its research to the United States, prompting German politicians to insist no country should have a monopoly on any future vaccine. Germany’s Health Ministry confirmed a report in newspaper Welt am Sonntag, which said President Donald Trump had offered funds to lure the company CureVac to the United States, and the German government was making counter-offers to tempt it to stay.

Welt reported that an unidentified German government source said that Trump was trying to secure the scientists’ work exclusively and would do anything to get a vaccine for the United States, but only for the United States.

CureVac pharmaceutical company in its press release on 03 March 2020, reported that Daniel Menichella, CEO of the biopharmaceutical company CureVac, was invited on 02 March 2020 to the White House to discuss strategies and opportunities for the rapid development and production of a coronavirus vaccine with the U.S. President Donald Trump, Vice President Mike Pence, members of the White House Coronavirus Task Force and high-ranking representatives of pharmaceutical and biotech companies working on the outbreak’s response.

The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.